Thunberginols A, B, and F from the processed leaves of Hydrangea macrophylla var. thunbergii (Hydrangeae Dulcis Folium) substantially inhibited the degranulations by antigen and calcium ionophore A23187, and the releases of TNF-a a and IL-4 by antigen in RBL-2H3 cells. Phyllodulcin and hydrangenol also showed significant inhibition for the antigen-induced degranulations, but their effects were weaker than those of thunberginols A, B, and F. Among them, thunberginol B showed the most potent activity. With regard to structural requirements of thunberginols for the activity, the 3,4-double bond was essential for the strong activity and the 6-hydroxyl group and lactone ring enhanced the activity. Thunberginols A, B, and F inhibited increase in intracellular free Ca 2؉ levels, which is an essential process for the degranulation and production of cytokines, in RBL-2H3 cells induced by antigen, but not by calcium ionophore A23187. These results suggested that these active compounds inhibited the degranulation processes both before and after increase in intracellular free Ca 2؉ levels.
Basophils as well as mast cells play important roles in
] i ) plays an essential role in the degranulation process. [1] [2] [3] Furthermore, mast cells and basophils concomitantly synthesize and release a variety of cytokines including interleukin (IL)-3, IL-4, granulocyte-macrophage colony-stimulating factor (GM-CSF), tumor necrosis factor a (TNF-a), and these cytokines induce the late-phase reactions, production of IgE, etc. 1) Thunberginols A (1), B (2), and F (5) (Fig. 1) were isolated from Hydrangeae Dulcis Folium, the fermented leaves of Hydrangea macrophylla SERINGE var. thunbergii MAKINO, as antiallergic constituents. [4] [5] [6] [7] In the previous study, we reported that compounds 1, 2, and 5 inhibited histamine release from rat peritoneal mast cells stimulated by compound 48/80, calcium ionophore A23187, or antigen, [6] [7] [8] and oral administration of compound 1 inhibited passive cutaneous anaphylaxis reactions in rats. 9, 10) However, their inhibitory effects on the antigen-induced degranulation and release of cytokines in basophils have not been reported to date.
In our continuing study, we examined the effects of the isolated compounds [thunberginols A (1), B (2), C (3), E (4), and F (5), phyllodulcin (7), hydrangenol (8) ] from Hy-drangeae Dulicis Folium, thunberginol G (6) and 3Ј-hydroxyhydrangeaic acid (9) derived from 7 on the degranulations and/or releases of TNF-a and IL-4 via FceRI signaling in rat basophilic leukemia (RBL-2H3) cells. In addition, effects of the active constituents on increase in [Ca 2ϩ ] i were examined to get some information for their mechanism of action.
MATERIALS AND METHODS
Isolation Thunberginols A (1), B (2), C (3), E (4), and F (5), phyllodulcin (7) , and hydrangenol (8) were isolated from Hydrangeae Dulcis Folium, and thunberginol G (6) and 3Ј-hydroxyhydrangeaic acid (9) were derived from 7 as described in our previous reports. [4] [5] [6] [7] 11) Reagents Eagle's minimum essential medium (MEM) and anti-DNP IgE (Monoclonal Anti-DNP) were purchased from Sigma; fetal calf serum (FCS) was from Gibco; the ELISA kits for determination of TNF-a (TNF-a, rat) and IL-4 (IL-4, rat) were from Amersham Pharmacia Biotech; Calcium Kit-Fluo 3 TM from Dojindo Laboratories; the dinitrophenylated bovine serum albumin (DNP-BSA) was prepared as described previously, 9, 12) and other chemicals were from Wako Pure Chemical Industries. 24-Well multiplates and 96-well microplates were from Sumitomo Bakelite; 96-well black microplates were from Nunc.
Inhibitory Effects on the Release of b b-Hexosaminidase from RBL-2H3 Cells and on Enzyme Activity of b b-Hexosaminidase As a marker of the degranulation of RBL-2H3 cells, release of b-hexosaminidase into the medium was determined as described previously. 13, 14) Briefly, RBL-2H3 cells [Cell No. JCRB0023, obtained from Health Science Research Resources Bank (Osaka, Japan)] in MEM containing 10% FCS and penicillin (100 units/ml) and streptomycin (100 mg/ml) were seeded into 24-well multiplates at the density of 2ϫ10 5 cells per well and were incubated with anti-DNP IgE antibody (0.45 mg/ml) for sensitization of the cells. Then, the cells were washed twice with Siraganian buffer (119 mM NaCl, 5 mM KCl, 0.4 mM MgCl 2 , 25 mM PIPES, and 40 mM NaOH, pH 7.2) supplemented with 5.6 mM glucose, 1 mM CaCl 2 , and 0.1% bovine serum albumin (BSA) and incubated in 160 ml of buffer for 10 min at 37°C. Then, cells were added with 20 ml of test sample solution, and were stimulated with 20 ml of DNP-BSA (final conc. 10 mg/ml) as an antigen or calcium ionophores A23187 (final conc. 0.3 mM) for 10 min. The reaction was stopped by cooling in an ice bath for 10 min. The supernatant (50 ml) was transferred into a 96-well microplate and incubated with 50 ml of substrate 
Tranilast and ketotifen fumarate 14) were used as reference compounds. Under these conditions, it was calculated that 40-70% of b-hexosaminidase was released from the cells in the control groups by determination of the total b-hexosaminidase activity after sonication of the cell suspension. To clarify that the anti-allergic effects of samples are due to the inhibition of b-hexosaminidase release, but not the false positive from the inhibition of b-hexosaminidase activity, the cell suspension (5ϫ10 7 cells) in 5 ml of Siraganian buffer was sonicated. The solution was then centrifuged, and the supernatant was diluted with the incubation buffer and adjusted to the equal enzyme activity of the degranulation tested above. The enzyme solution (45 ml) and test sample solution (5 ml) were transferred into a 96-well microplate and enzyme activity was examined as described above.
Inhibitory Effects on Antigen-Induced Releases of TNF-a a and IL-4 from RBL-2H3 Cells RBL-2H3 cells (2ϫ10 5 cells/well) were sensitized with anti-DNP IgE as described above. The cells were washed twice with 500 ml of MEM containing 10% FCS, pencillin (100 units/ml), and streptomycin (100 mg/ml), and exchanged with 320 ml of the fresh medium. Then, 40 ml of test sample solution and 40 ml of antigen (DNP-BSA, final conc. 10 mg/ml) were added to each well and incubated at 37°C for 4 h. The supernatant (50 ml) was transferred into a 96-well ELISA plate and TNFa and IL-4 concentrations were determined using commercial kits (Amersham). The test samples were dissolved in DMSO, and the solution was added to MEM (final DMSO conc. was 0.1%). The inhibition (%) of the releases of TNFa and IL-4 by the test sample was calculated by the following equation, and IC 50 values were determined graphically: ). Then, 10 ml of test sample solution (0.1% DMSO) was added to each well and incubated in FLUOstar OPTIMA (BMG Labtechnologies, Offenburg, Germany) at 37°C, and the fluorescence of the solution was monitored for 2 min before stimulation and 8 min after stimulation (ex. 485 nm, ex. 520 nm). After 5th determination, 10 ml of antigen (DNP-BSA, final conc. was 10 mg/ml) were added to each well. The inhibition (%) of increase in fluorescence intensity (DRFU) by the test sample 8 min after stimulation was calculated by the following equation, and IC 50 values were determined graphically: E (4) , and G (6), phyllodulcin (7), and hydrangenol (8) (3, 6, 7, 8 ) except for 4 (IC 50 ϭ48 mM) showed weak inhibition of the degranulation by 14-52% at 100 mM (Table 1) . To confirm that the anti-allergic effects of these active compounds are due to the inhibition on release of b-hexosaminidase, but not the false positive due to the inhibition of enzyme activity of b-hexosaminidase, effects of compounds 1, 2, and 5 on the enzyme activity were examined. As a result, compounds 1, 2, and 5 showed only a weak inhibition against enzyme activity of bhexosaminidase by 17, 8, and 25% at 100 mM.
With regard to the structure-activity relationships, we previously reported some structural requirements of 3-phenylioscoumarins for degranulation using rat peritoneal mast cells. Briefly, the 3,4-double bond is essential for the strong activity, and the hydroxyl groups at the 8-, 3Ј-, and 4Ј-positions of thunberginols, but the 6-hydroxyl group is not important, and a lactone moiety enhanced the activity. 8) In agreement with the previous report, the activities of 1 and 2 having the 3,4-double bond showed stronger activities than those of 3, 4, 6, 7, and 8 lacking the 3,4-double bond [e.g. 1 (IC 50 ϭ17 mM)Ͼ6 (Ͼ100 mM)] indicating that the 3,4-double bond is essential for the strong anti-degranulation activity. In our previous study about effects on the degranulation, 13) piceatannol (3,3Ј,4Ј,5-tetrahydroxystilbene) showed significant inhibition of degranulation in the same bioassay methods (IC 50 ϭ24 mM), but the inhibitory effect was weaker than that of 2 having lactone moiety. In the present study, 3Ј-hydroxyhydrangeaic acid (9) lacked the activity. These results indicate the importance of lactone moiety for the strong ac- 
tivity.
On the other hand, different from the previous report, 8) the activities of 2, 3, and 4 having the 6-hydroxyl groups were stronger than those of 1, 7, and 8 lacking the 6-hydroxyl group [2 (5.7 mM)Ͼ1 (17 mM), 4 (48 mM)Ͼ7 (ca. 90 mM), 3 (inhibition at 100 mM: 43.6%)м8 (36.3%)] and methylation of the 4Ј-hydroxyl group tended to enhance the activity [7 (inhibition at 100 mM: 51.5%)Ͼ6 (13.6%)].
In addition, compounds 1, 2, and 5 were reported to show inhibitory activity for degranulation induced by calcium ionophore A23187 in mouse peritoneal mast cells. 8) In agreement with the previous report, compounds 1, 2, and 5 inhibited the release of b-hexosaminidase, but not 7 and 8, in RBL-2H3 cells. ] i is followed by the movement of granules to plasma membrane followed by the degranulation of mast cells or basophils and activates the formation of inflammatory mediators such as prostaglandins and leukotrienes.
Effects of Thunberginols A (1), B (2), and F (5) on
1) Therefore, we examined effects of thunberginols A (1), B (2), and F (5) on increase in [Ca 2ϩ ] i induced by antigen and/or calcium ionophore A23187 in RBL-2H3 cells using calcium probe Fluo 3-AM.
As shown in 1) The inhibitory effects on releases of TNF-a and IL-4 were examined by ELISA method. In pre-examination about releases of them in the medium, the releases in the medium reached to the maximum level 2-4 h after stimulation (data not shown). As shown in Table 3 , thunberginols A (1), B (2), and F (5) substantially inhibited releases of TNF-a and/or IL-4 in the culture medium 4 h after the stimulation. Among them, 2 showed the strongest activity.
In conclusion, the 3-phenylisocoumarins [thunberginols A (1) and B (2)] and a benzylidenephthalide [thunberginol F (5) ] from the processed leaves of Hydrangea macrophylla var. thunbergii (Hydrangeae Dulcis Folium) substantially inhibited the degranulation by antigen and calcium ionophore A23187, and the releases of TNF-a and IL-4 by antigen in RBL-2H3 cells. With regard to structural requirements of the 3-phenylisocoumarins for the activity, the 3,4-double bond was essential for the strong activity and the 6-hydroxyl group and lactone ring enhanced the activity. The active compounds 1, 2, and 5 inhibited increase in [Ca 2ϩ ] i in RBL-2H3 cells induced by antigen, but not by calcium ionophore A23187.
